Detalhe da pesquisa
1.
Mepirapim, a novel synthetic cannabinoid, induces Parkinson's disease-related behaviors by causing maladaptation of the dopamine system in the brain.
Arch Toxicol
; 97(2): 581-591, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36355181
2.
Pyrrolidine-based 3-deoxysphingosylphosphorylcholine analogs as possible candidates against neglected tropical diseases (NTDs): identification of hit compounds towards development of potential treatment of Leishmania donovani.
J Enzyme Inhib Med Chem
; 36(1): 1922-1930, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34425714
3.
Mepirapim, a Novel Synthetic Cannabinoid, Induces Addiction-Related Behaviors through Neurochemical Maladaptation in the Brain of Rodents.
Pharmaceuticals (Basel)
; 15(6)2022 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35745629
4.
Mosloflavone-Resveratrol Hybrid TMS-HDMF-5z Exhibits Potent In Vitro and In Vivo Anti-Inflammatory Effects Through NF-κB, AP-1, and JAK/STAT Inactivation.
Front Pharmacol
; 13: 857789, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35529447
5.
Abuse Potential of Synthetic Cannabinoids: AM-1248, CB-13, and PB-22.
Biomol Ther (Seoul)
; 29(4): 384-391, 2021 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33935046
6.
1-Phenylcyclohexan-1-amine hydrochloride (PCA HCl) alters mesolimbic dopamine system accompanied by neuroplastic changes: A neuropsychopharmacological evaluation in rodents.
Neurochem Int
; 144: 104962, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33460722